742 combined drugs to be in non-NHI reimbursement scheme.

As planned 742 combined drugs are excluded from the NHI reimbursement schedule taking effects from Nov. 1., under which many of them seem to be returned in fear of idle stocks at the pharmacy shelf.

The Drug Review Commission determined that 742 non-prescription combined drugs should be deleted from the NHI reimbursement schedule starting from Nov. 1 after 3 month probation terms when it wa...